Atria Wealth Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$512K	Sell	6,133 -5,977	-49%	-$477K	0.01%	900
2025 Q1	$982K	Sell	12,110 -2,438	-17%	-$218K	0.01%	908
2024 Q4	$1.31M	Buy	14,548 +2,822	+24%	+$273K	0.01%	816
2024 Q3	$1.16M	Sell	11,726 -4,871	-29%	-$479K	0.01%	857
2024 Q2	$1.54M	Buy	16,597 +5,962	+56%	+$535K	0.02%	725
2024 Q1	$1.01M	Buy	10,635 +1,251	+13%	+$116K	0.01%	904
2023 Q4	$838K	Buy	9,384 +5,586	+147%	+$415K	0.01%	945
2023 Q3	$277K	Sell	3,798 -1,827	-32%	-$146K	﹤0.01%	1464
2023 Q2	$468K	Buy	5,625 +2,946	+110%	+$246K	0.01%	1189
2023 Q1	$204K	Sell	2,679 -5,138	-66%	-$426K	﹤0.01%	1667
2022 Q4	$649K	Sell	7,817 -3,725	-32%	-$302K	0.01%	959
2022 Q3	$915K	Buy	11,542 +6,439	+126%	+$543K	0.02%	742
2022 Q2	$379K	Sell	5,103 -5,350	-51%	-$402K	0.01%	1097
2022 Q1	$940K	Buy	+10,453	New	+$965K	0.02%	764